The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 04, 2003

Filed:

Oct. 21, 1998
Applicant:
Inventors:

Edgardo Delfino Carosella, Paris, FR;

Jean Dausset, Paris, FR;

Marek Kirszenbaum, Paris, FR;

Pascale Paul, Paris, FR;

Nathalie Rouas-Freiss, Paris, FR;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 5/02 ; C12N 1/500 ; C12N 1/563 ; C07H 2/104 ; A61K 4/800 ;
U.S. Cl.
CPC ...
C12N 5/02 ; C12N 1/500 ; C12N 1/563 ; C07H 2/104 ; A61K 4/800 ;
Abstract

The invention concerns the use of a eukaryotic cell coding for at least an HLA-G isoform, to obtain an immunomodulating medicine for inhibiting the activity of killer cells, in particular NK cells and/or for inhibiting the primary allogenic response, in parthologies or situations in which the killer cells are activated or for preparing a medicine to raise the inhibiting function of the isoform(s) expressed by said cells with respect to killer cells, in particular NK cells, in pathologies where these killer cells are inhibited by the molecule of the major histocompatibility complex of I HLA-G classes. The invention also concerns eukaryotic cells expressing at their surface at least an HLA-G isoform and their applications. The invention further concerns transgenic animals specifically expressing at least an HLA-G isoform.


Find Patent Forward Citations

Loading…